Ignite Creation Date:
2024-05-06 @ 6:29 PM
Last Modification Date:
2024-10-26 @ 2:48 PM
Study NCT ID:
NCT05673629
Status:
RECRUITING
Last Update Posted:
2023-11-08
First Post:
2022-12-30
Brief Title:
Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer
Sponsor:
Beijing Biostar Pharmaceuticals Co Ltd
Organization:
Beijing Biostar Pharmaceuticals Co Ltd
Organization Data
Organization:
Beijing Biostar Pharmaceuticals Co Ltd
Class:
INDUSTRY
Study ID:
BG01-2102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beijing Biostar Pharmaceuticals Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None